Trials / Completed
CompletedNCT02582125
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
ONO-4538 Multicenter, Open-label, Single-arm, Phase II Study in Advanced Non-small Cell Lung Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to investigate the safety and efficacy of ONO-4538 in subjects with stage IIIB/IV or recurrent non-small cell lung cancer unsuited to radical radiotherapy and resistant to a platinum-based chemotherapeutic regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-4538 |
Timeline
- Start date
- 2016-01-27
- Primary completion
- 2021-01-04
- Completion
- 2021-12-31
- First posted
- 2015-10-21
- Last updated
- 2025-03-24
Locations
8 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02582125. Inclusion in this directory is not an endorsement.